IFM Investors Pty Ltd grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 11.9% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 39,802 shares of the company's stock after buying an additional 4,232 shares during the period. IFM Investors Pty Ltd's holdings in Cardinal Health were worth $6,687,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Principal Financial Group Inc. boosted its holdings in shares of Cardinal Health by 5.3% during the 1st quarter. Principal Financial Group Inc. now owns 315,817 shares of the company's stock worth $43,510,000 after buying an additional 15,956 shares in the last quarter. Kingswood Wealth Advisors LLC boosted its holdings in shares of Cardinal Health by 17.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock worth $429,000 after buying an additional 457 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of Cardinal Health by 25.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock worth $1,811,000 after buying an additional 2,694 shares in the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of Cardinal Health by 569.5% in the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company's stock worth $54,000 after purchasing an additional 336 shares in the last quarter. Finally, North Capital Inc. bought a new position in shares of Cardinal Health in the 1st quarter worth $83,000. 87.17% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the company. Argus set a $189.00 target price on Cardinal Health in a report on Friday, August 22nd. Robert W. Baird increased their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a report on Wednesday, August 13th. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Bank of America increased their target price on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Finally, Evercore ISI cut their target price on Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a report on Wednesday, August 13th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and an average price target of $165.93.
View Our Latest Analysis on Cardinal Health
Cardinal Health Stock Up 3.7%
CAH traded up $5.50 during trading hours on Tuesday, hitting $152.97. The stock had a trading volume of 1,569,233 shares, compared to its average volume of 2,386,241. The company's fifty day simple moving average is $152.78 and its 200 day simple moving average is $148.84. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44. The stock has a market cap of $36.34 billion, a PE ratio of 23.73, a price-to-earnings-growth ratio of 1.27 and a beta of 0.73.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter last year, the company earned $1.84 EPS. The firm's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.
Insiders Place Their Bets
In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jason M. Hollar sold 107,705 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the completion of the transaction, the chief executive officer owned 235,901 shares of the company's stock, valued at approximately $35,125,658.90. This represents a 31.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 271,676 shares of company stock worth $40,489,525 over the last quarter. Insiders own 0.12% of the company's stock.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report